跳至主要内容
临床试验/IRCT201104166202N1
IRCT201104166202N1已完成2 期

Effects of adjunct low-dose vitamin D on relapsing-remitting multiple sclerosis progression: Preliminary findings of a randomized, placebo-controlled trial

Isfahan University of Medical Sciences0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
15 years 至 60 years(—)
性别
All

入选标准

  • either sex, age between 15 and 60 years, diagnosis of definite RRMS with a MRI, clinical or laboratory, mean (standard deviation) duration equal to 4.3 (2.2) years, range 1-12 years, stable neurological functioning for at least one month prior to the study entry, EDSS score =6, serum 25-hydroxyvitamin D level> 40 ng/ml, willingness to continue current medications for the duration of the study
  • Exclusion criteria: evidence of substantial abnormalities in neurological, psychiatric, cardiac, endocrinological, hematologic, hepatic, renal, or metabolic functions, use of digitalis, vitamin D supplement, any condition predisposing to hypercalcemia, nephrolithiasis, renal insufficiency, pregnancy as determined by history, physical examination and screening blood tests. secondary-progressive and primary-progressive MS, Women in child-bearing age with no clinically-accepted method of contraception

排除标准

  • 未提供

研究者

相似试验